The 3rd Lifecycle Management for Combination Products Summit
Thank you to everyone who joined us at the 2nd CPLM Summit.
Lifecycle management for drug-device combination product has stolen the spotlight amongst pharma, biotechs and device developers. Integrating multiple project teams and defining a common LCM program can be difficult – but there is serious potential and benefits of having such a mind-set and implementing a robust LCM program from the get-go.
As the only peer-led community, 100+ senior leaders from drug-device teams, including the regulatory affairs, product development and quality, met at CPLM to share their view and encourage collaborative efforts.
In 2020, the 3rd Life Cycle Management for Combination Products summit will return to discuss LCM and design control, emphasising the implication of the EU MDR, post-market surveillance and how to manage design and change control to maintain market dominance.
Download the Preliminary Agenda to see how this meeting can maximize your combination products’ lifespan and continue to deliver a quality drug-device product for your patients in 2020.